Literature DB >> 20473951

Prognostic significance of regulatory T cells in tumor.

Cailin Moira Wilke1, Ke Wu, Ende Zhao, Guobin Wang, Weiping Zou.   

Abstract

Since entering the immunological stage several decades ago, regulatory T cell biology has been realized as fundamentally important in the prevention of autoimmune conditions, induction of transplant tolerance and the immune response to cancer. The role of regulatory T cells in tumor immunobiology is still being elucidated. Currently, regulatory T cells are implicated in the dampening of antitumor T-cell responses both through direct and indirect means. A number of investigators have demonstrated that regulatory T cell density and location may serve as independent prognostic factors in several types of cancer and are alternately detrimental or beneficial to patient survival. In this article, we will review the characteristics and functional phenotype of classical regulatory T cells, describe their distribution and quantification in tumor-bearing hosts and summarize recent studies investigating the prognostic significance of regulatory T cell number and locality in various cancers.

Entities:  

Mesh:

Year:  2010        PMID: 20473951     DOI: 10.1002/ijc.25464

Source DB:  PubMed          Journal:  Int J Cancer        ISSN: 0020-7136            Impact factor:   7.396


  54 in total

Review 1.  Tumor-infiltrating lymphocytes and hepatocellular carcinoma: molecular biology.

Authors:  Nobuyoshi Hiraoka
Journal:  Int J Clin Oncol       Date:  2010-10-06       Impact factor: 3.402

Review 2.  Cancer immunology--analysis of host and tumor factors for personalized medicine.

Authors:  Shuji Ogino; Jérôme Galon; Charles S Fuchs; Glenn Dranoff
Journal:  Nat Rev Clin Oncol       Date:  2011-08-09       Impact factor: 66.675

3.  Intratumoral regulatory T cells alone or in combination with cytotoxic T cells predict prognosis of hepatocellular carcinoma after resection.

Authors:  Kang-jie Chen; Lin Zhou; Hai-yang Xie; Taki-eldin Ahmed; Xiao-wen Feng; Shu-sen Zheng
Journal:  Med Oncol       Date:  2011-06-16       Impact factor: 3.064

4.  The bone marrow of myeloma patients is steadily inhabited by a normal-sized pool of functional regulatory T cells irrespectiveof the disease status.

Authors:  Myriam Foglietta; Barbara Castella; Sara Mariani; Marta Coscia; Laura Godio; Riccardo Ferracini; Marina Ruggeri; Vittorio Muccio; Paola Omedé; Antonio Palumbo; Mario Boccadoro; Massimo Massaia
Journal:  Haematologica       Date:  2014-06-27       Impact factor: 9.941

5.  A bispecific nanobody approach to leverage the potent and widely applicable tumor cytolytic capacity of Vγ9Vδ2-T cells.

Authors:  Renée C G de Bruin; John P Veluchamy; Sinéad M Lougheed; Famke L Schneiders; Silvia Lopez-Lastra; Roeland Lameris; Anita G Stam; Zsolt Sebestyen; Jürgen Kuball; Carla F M Molthoff; Erik Hooijberg; Rob C Roovers; James P Di Santo; Paul M P van Bergen En Henegouwen; Henk M W Verheul; Tanja D de Gruijl; Hans J van der Vliet
Journal:  Oncoimmunology       Date:  2017-10-20       Impact factor: 8.110

6.  Interleukin-21 (IL-21) synergizes with IL-2 to enhance T-cell receptor-induced human T-cell proliferation and counteracts IL-2/transforming growth factor-β-induced regulatory T-cell development.

Authors:  Alessandra Battaglia; Alexia Buzzonetti; Cinzia Baranello; Mara Fanelli; Marco Fossati; Valentina Catzola; Giovanni Scambia; Andrea Fattorossi
Journal:  Immunology       Date:  2013-05       Impact factor: 7.397

Review 7.  Circulating and disseminated tumour cells - mechanisms of immune surveillance and escape.

Authors:  Malte Mohme; Sabine Riethdorf; Klaus Pantel
Journal:  Nat Rev Clin Oncol       Date:  2016-09-20       Impact factor: 66.675

8.  Generation of T cell effectors using tumor cell-loaded dendritic cells for adoptive T cell therapy.

Authors:  Katerina Vavrova; Petra Vrabcova; Dominik Filipp; Jirina Bartunkova; Rudolf Horvath
Journal:  Med Oncol       Date:  2016-11-03       Impact factor: 3.064

9.  Hyperthermic intraperitoneal chemotherapy leads to an anticancer immune response via exposure of cell surface heat shock protein 90.

Authors:  B Zunino; C Rubio-Patiño; E Villa; O Meynet; E Proics; A Cornille; S Pommier; L Mondragón; J Chiche; J-M Bereder; M Carles; J-E Ricci
Journal:  Oncogene       Date:  2015-04-13       Impact factor: 9.867

Review 10.  Immunobiology of hepatocarcinogenesis: Ways to go or almost there?

Authors:  Pavan Patel; Steven E Schutzer; Nikolaos Pyrsopoulos
Journal:  World J Gastrointest Pathophysiol       Date:  2016-08-15
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.